These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

829 related items for PubMed ID: 16406146

  • 21. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.
    Dong Z, Ferger B, Feldon J, Büeler H.
    J Neurobiol; 2002 Oct; 53(1):1-10. PubMed ID: 12360578
    [Abstract] [Full Text] [Related]

  • 22. The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro.
    Mazzio EA, Reams RR, Soliman KF.
    Brain Res; 2004 Apr 09; 1004(1-2):29-44. PubMed ID: 15033417
    [Abstract] [Full Text] [Related]

  • 23. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A, Rota D, Debetto P, Peroni D, Guidolin D, Negro A, Skaper SD, Giusti P.
    Neurobiol Dis; 2008 Apr 09; 30(1):8-18. PubMed ID: 18313315
    [Abstract] [Full Text] [Related]

  • 24. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease.
    Afonso-Oramas D, Cruz-Muros I, Alvarez de la Rosa D, Abreu P, Giráldez T, Castro-Hernández J, Salas-Hernández J, Lanciego JL, Rodríguez M, González-Hernández T.
    Neurobiol Dis; 2009 Dec 09; 36(3):494-508. PubMed ID: 19766189
    [Abstract] [Full Text] [Related]

  • 25. Dopaminergic neurotoxicity by 6-OHDA and MPP+: differential requirement for neuronal cyclooxygenase activity.
    Carrasco E, Casper D, Werner P.
    J Neurosci Res; 2005 Jul 01; 81(1):121-31. PubMed ID: 15931668
    [Abstract] [Full Text] [Related]

  • 26. Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death.
    Kaul S, Anantharam V, Kanthasamy A, Kanthasamy AG.
    Brain Res Mol Brain Res; 2005 Sep 13; 139(1):137-52. PubMed ID: 15978696
    [Abstract] [Full Text] [Related]

  • 27. Alpha-synuclein protects cerebellar granule neurons against 6-hydroxydopamine-induced death.
    Monti B, Polazzi E, Batti L, Crochemore C, Virgili M, Contestabile A.
    J Neurochem; 2007 Oct 13; 103(2):518-30. PubMed ID: 17635667
    [Abstract] [Full Text] [Related]

  • 28. [Proteolytic stress induced by environmental toxins in dopaminergic neurons: an experimental study].
    Wang L, Cao XB, Wang JM, Qu RS, Xu L, Qiao X, Sun SG.
    Zhonghua Yi Xue Za Zhi; 2007 May 08; 87(17):1190-4. PubMed ID: 17686240
    [Abstract] [Full Text] [Related]

  • 29. Over-expression of alpha-synuclein in human neural progenitors leads to specific changes in fate and differentiation.
    Schneider BL, Seehus CR, Capowski EE, Aebischer P, Zhang SC, Svendsen CN.
    Hum Mol Genet; 2007 Mar 15; 16(6):651-66. PubMed ID: 17309880
    [Abstract] [Full Text] [Related]

  • 30. Effect of sublethal 6-hydroxydopamine on the response to subsequent oxidative stress in dopaminergic cells: evidence for preconditioning.
    Leak RK, Liou AK, Zigmond MJ.
    J Neurochem; 2006 Nov 15; 99(4):1151-63. PubMed ID: 16956375
    [Abstract] [Full Text] [Related]

  • 31. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, a Parkinsonism-inducing endogenous toxin, increases alpha-synuclein expression and causes nuclear damage in human dopaminergic cells.
    Shavali S, Carlson EC, Swinscoe JC, Ebadi M.
    J Neurosci Res; 2004 May 15; 76(4):563-71. PubMed ID: 15114628
    [Abstract] [Full Text] [Related]

  • 32. PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity.
    Carrasco E, Casper D, Werner P.
    J Neurosci Res; 2007 Nov 01; 85(14):3109-17. PubMed ID: 17868147
    [Abstract] [Full Text] [Related]

  • 33. Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by alpha-synuclein.
    Park SS, Schulz EM, Lee D.
    Eur J Neurosci; 2007 Dec 01; 26(11):3104-12. PubMed ID: 18005066
    [Abstract] [Full Text] [Related]

  • 34. Expression of mutant alpha-synucleins enhances dopamine transporter-mediated MPP+ toxicity in vitro.
    Lehmensiek V, Tan EM, Schwarz J, Storch A.
    Neuroreport; 2002 Jul 19; 13(10):1279-83. PubMed ID: 12151787
    [Abstract] [Full Text] [Related]

  • 35. Alpha-synuclein and its neurotoxic fragment inhibit dopamine uptake into rat striatal synaptosomes. Relationship to nitric oxide.
    Adamczyk A, Kaźmierczak A, Strosznajder JB.
    Neurochem Int; 2006 Sep 19; 49(4):407-12. PubMed ID: 16546300
    [Abstract] [Full Text] [Related]

  • 36. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM, Chen X, Luo DZ, Zhang XH, Xue H, Zheng LF, Yang N, Wang XM, Zhu JX.
    Neuroscience; 2008 May 15; 153(3):634-44. PubMed ID: 18420351
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.